Study of Ipilimumab and Dasatinib Combination Therapy in Patients With Chronic or Accelerated Chronic Myeloid Leukemia
Clinical trial NCT00732186 · WITHDRAWN
Trial details
- NCT number
- NCT00732186
- Sponsor
- Bristol-Myers Squibb
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2011-02-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.